- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Market Overview
The Opioids Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Opioids Drug sales will be xx in 2020 from Opioids Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Opioids Drug market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Opioids Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Opioids Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Opioids Drug market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Opioids Drug market has been segmented into Oxycodone, Hydromorphone, Codeine, Fentanyl, Other, etc.
Breakdown by Application, Opioids Drug has been segmented into Pain Relief, Anesthesia, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioids Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioids Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioids Drug market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Opioids Drug Market Share Analysis
Opioids Drug competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Opioids Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioids Drug sales, revenue and market share for each player covered in this report.
The major players covered in Opioids Drug are: Teva, Pfizer, Amneal Pharma, Purdue Pharma, Endo, Mallinckrodt, Mylan, J&J, Collegium, INSYS, Hikma, Egalet, etc. Among other players domestic and global, Opioids Drug market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Opioids Drug market are listed below:
Teva
Pfizer
Amneal Pharma
Purdue Pharma
Endo
Mallinckrodt
Mylan
J&J
Collegium
INSYS
Hikma
Egalet
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Market segment by Application, can be divided into
Pain Relief
Anesthesia
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Opioids Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioids Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioids Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Other
1.4 Global Opioids Drug Market Size and Forecast (2015-2025)
1.4.1 Global Opioids Drug Revenue and Forecast (2015-2025)
1.4.2 Global Opioids Drug Sales and Forecast (2015-2025)
1.5 Global Opioids Drug Market Size Overview by Geography (2015-2020)
1.6 COVID-19 Outbreak: Opioids Drug Industry Impact
1.6.1 COVID-19 Potential Implications for the Opioids Drug
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Opioids Drug
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amneal Pharma
2.3.1 Amneal Pharma Details
2.3.2 Amneal Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amneal Pharma SWOT Analysis
2.3.4 Amneal Pharma Product and Services
2.3.5 Amneal Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Purdue Pharma
2.4.1 Purdue Pharma Details
2.4.2 Purdue Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Purdue Pharma SWOT Analysis
2.4.4 Purdue Pharma Product and Services
2.4.5 Purdue Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Endo
2.5.1 Endo Details
2.5.2 Endo Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Endo SWOT Analysis
2.5.4 Endo Product and Services
2.5.5 Endo Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mallinckrodt
2.6.1 Mallinckrodt Details
2.6.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mallinckrodt SWOT Analysis
2.6.4 Mallinckrodt Product and Services
2.6.5 Mallinckrodt Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 J&J
2.8.1 J&J Details
2.8.2 J&J Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 J&J SWOT Analysis
2.8.4 J&J Product and Services
2.8.5 J&J Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Collegium
2.9.1 Collegium Details
2.9.2 Collegium Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Collegium SWOT Analysis
2.9.4 Collegium Product and Services
2.9.5 Collegium Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 INSYS
2.10.1 INSYS Details
2.10.2 INSYS Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 INSYS SWOT Analysis
2.10.4 INSYS Product and Services
2.10.5 INSYS Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Hikma SWOT Analysis
2.11.4 Hikma Product and Services
2.11.5 Hikma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Egalet SWOT Analysis
2.12.4 Egalet Product and Services
2.12.5 Egalet Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Opioids Drug Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Opioids Drug Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Opioids Drug Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players Opioids Drug Sales in China (2018-2019)
3.2.2 China Opioids Drug Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioids Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Opioids Drug Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Opioids Drug Market Size by Geography (2015-2020)
4.1.1 Global Opioids Drug Sales by Geography (2015-2020)
4.1.2 Global Opioids Drug Revenue by Regions (2015-2020)
4.2 Global Opioids Drug Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Opioids Drug Sales and Forecast by Regions (2020-2025)
4.2.2 Global Opioids Drug Revenue and Forecast by Regions (2020-2025)
4.3 North America Opioids Drug Market Size and Forecast (2015-2025)
4.4 Europe Opioids Drug Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Opioids Drug Market Size and Forecast (2015-2025)
4.6 South America Opioids Drug Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Opioids Drug Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Opioids Drug Market Size by Country (2015-2020)
5.1.1 North America Opioids Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Opioids Drug Revenue and Market Share by Country (2015-2020)
5.2 North America Opioids Drug Market Size and Forecast by Country (2020-2025)
5.2.1 North America Opioids Drug Sales and Forecast by Country (2020-2025)
5.2.2 North America Opioids Drug Revenue and Forecast by Country (2020-2025)
5.3 United States Opioids Drug Market Size and Forecast (2015-2025)
5.4 Canada Opioids Drug Market Size and Forecast (2015-2025)
5.5 Mexico Opioids Drug Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Opioids Drug Market Size by Country (2015-2020)
6.1.1 Europe Opioids Drug Sales by Country (2015-2020)
6.1.2 Europe Opioids Drug Revenue by Country (2015-2020)
6.2 Europe Opioids Drug Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Opioids Drug Sales and Forecast by Country (2020-2025)
6.2.2 Europe Opioids Drug Revenue and Forecast by Country (2020-2025)
6.3 Germany Opioids Drug Market Size and Forecast (2015-2025)
6.4 United Kingdom Opioids Drug Market Size and Forecast (2015-2025)
6.5 France Opioids Drug Market Size and Forecast (2015-2025)
6.6 Russia Opioids Drug Market Size and Forecast (2015-2025)
6.7 Italy Opioids Drug Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Opioids Drug Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Opioids Drug Sales by Region (2015-2020)
7.1.2 Asia-Pacific Opioids Drug Revenue by Region (2015-2020)
7.2 Asia-Pacific Opioids Drug Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Opioids Drug Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Opioids Drug Revenue and Forecast by Region (2020-2025)
7.3 China Opioids Drug Market Size and Forecast (2015-2025)
7.4 Japan Opioids Drug Market Size and Forecast (2015-2025)
7.5 Korea Opioids Drug Market Size and Forecast (2015-2025)
7.6 India Opioids Drug Market Size and Forecast (2015-2025)
7.7 Southeast Asia Opioids Drug Market Size and Forecast (2015-2025)
7.8 Australia Opioids Drug Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Opioids Drug Market Size by Country (2015-2020)
8.1.1 South America Opioids Drug Sales by Country (2015-2020)
8.1.2 South America Opioids Drug Revenue by Country (2015-2020)
8.2 South America Opioids Drug Market Size and Forecast by Country (2020-2025)
8.2.1 South America Opioids Drug Sales and Forecast by Country (2020-2025)
8.2.2 South America Opioids Drug Revenue and Forecast by Country (2020-2025)
8.3 Brazil Opioids Drug Market Size and Forecast (2015-2025)
8.4 Argentina Opioids Drug Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Opioids Drug Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Opioids Drug Sales by Country (2015-2020)
9.1.2 Middle East & Africa Opioids Drug Revenue by Country (2015-2020)
9.2 Middle East & Africa Opioids Drug Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Opioids Drug Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Opioids Drug Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Opioids Drug Market Size and Forecast (2015-2025)
9.4 Turkey Opioids Drug Market Size and Forecast (2015-2025)
9.5 Egypt Opioids Drug Market Size and Forecast (2015-2025)
9.6 South Africa Opioids Drug Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Opioids Drug Market Size by Type (2015-2020)
10.1.1 Global Opioids Drug Sales by Type (2015-2020)
10.1.2 Global Opioids Drug Revenue by Type (2015-2020)
10.1.3 Global Opioids Drug Price by Type (2015-2020)
10.2 Global Opioids Drug Market Size and Forecast by Type (2020-2025)
10.2.1 Global Opioids Drug Sales and Forecast by Type (2020-2025)
10.2.2 Global Opioids Drug Revenue and Forecast by Type (2020-2025)
10.2.3 Global Opioids Drug Price and Forecast by Type (2020-2025)
10.3 China Opioids Drug Market Size and Forecast by Type (2015-2025)
10.3.1 China Opioids Drug Market Size by Type (2015-2020)
10.3.2 China Opioids Drug Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Opioids Drug Market Size by Application (2015-2020)
11.1.1 Global Opioids Drug Sales by Application (2015-2020)
11.1.2 Global Opioids Drug Revenue by Application (2015-2020)
11.1.3 Global Opioids Drug Price by Application (2015-2020)
11.2 Global Opioids Drug Market Size and Forecast by Application (2020-2025)
11.2.1 Global Opioids Drug Sales and Forecast by Application (2020-2025)
11.2.2 Global Opioids Drug Revenue and Forecast by Application (2020-2025)
11.2.3 Global Opioids Drug Price and Forecast by Application (2020-2025)
11.3 China Opioids Drug Market Size and Forecast by Application (2015-2025)
11.3.1 China Opioids Drug Market Size by Application (2015-2020)
11.3.2 China Opioids Drug Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Opioids Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Opioids Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Opioids Drug Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Global Opioids Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Teva Basic Information, Manufacturing Base and Competitors
Table 7. Teva Opioids Drug Major Business
Table 8. Teva Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 9. Teva SWOT Analysis
Table 10. Teva Opioids Drug Product and Services
Table 11. Teva Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 12. Pfizer Basic Information, Manufacturing Base and Competitors
Table 13. Pfizer Opioids Drug Major Business
Table 14. Pfizer Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 15. Pfizer SWOT Analysis
Table 16. Pfizer Opioids Drug Product and Services
Table 17. Pfizer Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 18. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Amneal Pharma Opioids Drug Major Business
Table 20. Amneal Pharma Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 21. Amneal Pharma SWOT Analysis
Table 22. Amneal Pharma Opioids Drug Product and Services
Table 23. Amneal Pharma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 24. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 25. Purdue Pharma Opioids Drug Major Business
Table 26. Purdue Pharma Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 27. Purdue Pharma SWOT Analysis
Table 28. Purdue Pharma Opioids Drug Product and Services
Table 29. Purdue Pharma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 30. Endo Basic Information, Manufacturing Base and Competitors
Table 31. Endo Opioids Drug Major Business
Table 32. Endo Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 33. Endo SWOT Analysis
Table 34. Endo Opioids Drug Product and Services
Table 35. Endo Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 36. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 37. Mallinckrodt Opioids Drug Major Business
Table 38. Mallinckrodt Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 39. Mallinckrodt SWOT Analysis
Table 40. Mallinckrodt Opioids Drug Product and Services
Table 41. Mallinckrodt Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 42. Mylan Basic Information, Manufacturing Base and Competitors
Table 43. Mylan Opioids Drug Major Business
Table 44. Mylan Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 45. Mylan SWOT Analysis
Table 46. Mylan Opioids Drug Product and Services
Table 47. Mylan Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 48. J&J Basic Information, Manufacturing Base and Competitors
Table 49. J&J Opioids Drug Major Business
Table 50. J&J Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 51. J&J SWOT Analysis
Table 52. J&J Opioids Drug Product and Services
Table 53. J&J Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 54. Collegium Basic Information, Manufacturing Base and Competitors
Table 55. Collegium Opioids Drug Major Business
Table 56. Collegium Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 57. Collegium SWOT Analysis
Table 58. Collegium Opioids Drug Product and Services
Table 59. Collegium Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 60. INSYS Basic Information, Manufacturing Base and Competitors
Table 61. INSYS Opioids Drug Major Business
Table 62. INSYS Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 63. INSYS SWOT Analysis
Table 64. INSYS Opioids Drug Product and Services
Table 65. INSYS Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 66. Hikma Basic Information, Manufacturing Base and Competitors
Table 67. Hikma Opioids Drug Major Business
Table 68. Hikma Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 69. Hikma SWOT Analysis
Table 70. Hikma Opioids Drug Product and Services
Table 71. Hikma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 72. Egalet Basic Information, Manufacturing Base and Competitors
Table 73. Egalet Opioids Drug Major Business
Table 74. Egalet Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 75. Egalet SWOT Analysis
Table 76. Egalet Opioids Drug Product and Services
Table 77. Egalet Opioids Drug Sales (M Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 78. Global Opioids Drug Sales by Manufacturer (2018-2019) (M Units)
Table 79. Global Opioids Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 80. Key Players Opioids Drug Sales in China (2018-2019) (M Units)
Table 81. Key Players Opioids Drug Sales Market Share in China (2018-2019)
Table 82. Key Players Revenue of Opioids Drug in China (2018-2019) (USD Million)
Table 83. Global Opioids Drug Sales by Regions (2015-2020) (M Units)
Table 84. Global Opioids Drug Sales Market Share by Regions (2015-2020)
Table 85. Global Opioids Drug Revenue by Regions (2015-2020) (USD Million)
Table 86. Global Opioids Drug Sales and Forecast by Regions (2020-2025) (M Units)
Table 87. Global Opioids Drug Sales Market Share by Regions (2020-2025)
Table 88. Global Opioids Drug Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 89. Global Opioids Drug Revenue Market Share by Regions (2020-2025) (USD Million)
Table 90. North America Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 91. North America Opioids Drug Sales Market Share by Countries (2015-2020)
Table 92. North America Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Opioids Drug Revenue Market Share by Countries (2015-2020)
Table 94. North America Opioids Drug Sales by Country (2020-2025) (M Units)
Table 95. North America Opioids Drug Sales Market Share by Country (2020-2025)
Table 96. North America Opioids Drug Revenue by Country (2020-2025) (USD Million)
Table 97. North America Opioids Drug Revenue Market Share by Country (2020-2025)
Table 98. Europe Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 99. Europe Opioids Drug Sales Market Share by Countries (2015-2020)
Table 100. Europe Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 101. Europe Opioids Drug Revenue Market Share by Countries (2015-2020)
Table 102. Europe Opioids Drug Sales by Country (2020-2025) (M Units)
Table 103. Europe Opioids Drug Sales Market Share by Country (2020-2025)
Table 104. Europe Opioids Drug Revenue by Country (2020-2025) (USD Million)
Table 105. Europe Opioids Drug Revenue Market Share by Country (2020-2025)
Table 106. Asia-Pacific Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 107. Asia-Pacific Opioids Drug Sales Market Share by Countries (2015-2020)
Table 108. Asia-Pacific Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Opioids Drug Revenue Market Share by Countries (2015-2020)
Table 110. Asia-Pacific Opioids Drug Sales by Country (2020-2025) (M Units)
Table 111. Asia-Pacific Opioids Drug Sales Market Share by Country (2020-2025)
Table 112. Asia-Pacific Opioids Drug Revenue by Country (2020-2025) (USD Million)
Table 113. Asia-Pacific Opioids Drug Revenue Market Share by Country (2020-2025)
Table 114. South America Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 115. South America Opioids Drug Sales Market Share by Countries (2015-2020)
Table 116. South America Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 117. South America Opioids Drug Revenue Market Share by Countries (2015-2020)
Table 118. South America Opioids Drug Sales by Country (2020-2025) (M Units)
Table 119. South America Opioids Drug Sales Market Share by Country (2020-2025)
Table 120. South America Opioids Drug Revenue by Country (2020-2025) (USD Million)
Table 121. South America Opioids Drug Revenue Market Share by Country (2020-2025)
Table 122. Middle East & Africa Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 123. Middle East & Africa Opioids Drug Sales Market Share by Countries (2015-2020)
Table 124. Middle East & Africa Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 125. Middle East & Africa Opioids Drug Revenue Market Share by Countries (2015-2020)
Table 126. Middle East & Africa Opioids Drug Sales by Country (2020-2025) (M Units)
Table 127. Middle East & Africa Opioids Drug Sales Market Share by Country (2020-2025)
Table 128. Middle East & Africa Opioids Drug Revenue by Country (2020-2025) (USD Million)
Table 129. Middle East & Africa Opioids Drug Revenue Market Share by Country (2020-2025)
Table 130. China Opioids Drug Sales by Type (2015-2020) (M Units)
Table 131. China Opioids Drug Sales Market Share by Type (2015-2020)
Table 132. China Opioids Drug Revenue by Type (2015-2020) (USD Million)
Table 133. China Opioids Drug Revenue Market Share by Type (2015-2020)
Table 134. China Opioids Drug Sales by Type (2020-2025) (M Units)
Table 135. China Opioids Drug Sales Market Share by Type (2020-2025)
Table 136. China Opioids Drug Revenue by Type (2020-2025) (USD Million)
Table 137. China Opioids Drug Revenue Market Share by Type (2020-2025)
Table 138. Global Opioids Drug Sales by Application (2015-2020) (M Units)
Table 139. Global Opioids Drug Sales Market Share by Application (2015-2020)
Table 140. Global Opioids Drug Revenue by Application (2015-2020) (USD Million)
Table 141. Global Opioids Drug Revenue Market Share by Application (2015-2020)
Table 142. Global Opioids Drug Price by Application (2015-2020) (USD/Unit)
Table 143. Global Opioids Drug Sales by Application (2020-2025) (M Units)
Table 144. Global Opioids Drug Sales Market Share by Application (2020-2025)
Table 145. Global Opioids Drug Revenue by Application (2020-2025) (USD Million)
Table 146. Global Opioids Drug Revenue Market Share by Application (2020-2025)
Table 147. Global Opioids Drug Price by Application (2020-2025) (USD/Unit)
Table 148. China Opioids Drug Sales by Application (2015-2020) (M Units)
Table 149. China Opioids Drug Sales Market Share by Application (2015-2020)
Table 150. China Opioids Drug Revenue by Application (2015-2020) (USD Million)
Table 151. China Opioids Drug Revenue Market Share by Application (2015-2020)
Table 152. China Opioids Drug Sales by Application (2020-2025) (M Units)
Table 153. China Opioids Drug Sales Market Share by Application (2020-2025)
Table 154. China Opioids Drug Revenue by Application (2020-2025) (USD Million)
Table 155. China Opioids Drug Revenue Market Share by Application (2020-2025)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Distributors/Traders/ Dealers List
Table 159. Customers of Opioids Drug
Table 160. Market Opportunities in Next Few Years
Table 161. Market Risks Analysis
Table 162. Market Drivers
List of Figures
Figure 1. Opioids Drug Picture
Figure 2. Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Oxycodone Picture
Figure 4. Hydromorphone Picture
Figure 5. Codeine Picture
Figure 6. Fentanyl Picture
Figure 7. Other Picture
Figure 8. Opioids Drug Sales Market Share by Application in 2019
Figure 9. Pain Relief Picture
Figure 10. Anesthesia Picture
Figure 11. Other Picture
Figure 12. Global Opioids Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. Global Opioids Drug Sales Growth Rate (2015-2025) (M Units)
Figure 14. Global Opioids Drug Sales Market Share by Manufacturer in 2019
Figure 15. Global Opioids Drug Revenue Market Share by Manufacturer in 2019
Figure 16. Key Players Opioids Drug Revenue Market Share in China in 2019
Figure 17. Global Top 5 Opioids Drug Manufacturer Market Share in 2019
Figure 18. Top 3 Opioids Drug Players Market Share in China in 2019
Figure 19. Global Opioids Drug Revenue Market Share by Regions in 2019
Figure 20. North America Opioids Drug Sales YoY Growth (2015-2025) (M Units)
Figure 21. North America Opioids Drug Revenue YoY Growth (2015-2025) (USD Million)
Figure 22. Europe Opioids Drug Sales YoY Growth (2015-2020) (M Units)
Figure 23. Europe Opioids Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Asia-Pacific Opioids Drug Sales YoY Growth (2015-2020) (M Units)
Figure 25. Asia-Pacific Opioids Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. South America Opioids Drug Sales YoY Growth (2015-2020) (M Units)
Figure 27. South America Opioids Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 28. Middle East & Africa Opioids Drug Sales YoY Growth (2015-2020) (M Units)
Figure 29. Middle East & Africa Opioids Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 30. North America Opioids Drug Sales Market Share by Country in 2019
Figure 31. North America Opioids Drug Revenue Market Share by Country in 2019
Figure 32. United States Opioids Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Canada Opioids Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 34. Mexico Opioids Drug Market Size and Growth Rate (2015-2020) (USD Million)
Figure 35. Europe Opioids Drug Revenue Market Share by Country in 2019
Figure 36. Germany Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. United Kingdom Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. France Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Russia Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Italy Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Asia-Pacific Opioids Drug Sales Market Share by Region 2018
Figure 42. Asia-Pacific Opioids Drug Revenue Market Share by Region 2018
Figure 43. China Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Japan Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Korea Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. India Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Southeast Asia Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Australia Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. South America Opioids Drug Sales Market Share by Country in 2019
Figure 50. South America Opioids Drug Revenue Market Share by Country in 2019
Figure 51. Brazil Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Argentina Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Saudi Arabia Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Turkey Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Egypt Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. South Africa Opioids Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Global Revenue Market Share of Opioids Drug by Type in 2019
Figure 58. Global Revenue Market Share of Opioids Drug by Application in 2019
Figure 59. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
